Levaquin for everyone!

On Wednesday, drugmaker Wockhardt said it has received tentative approval from the US Food & Drug Administration to marketing various doses of anti-bacterial Levofloxacin.

Levofloxacin is the generic name for the brand Levaquin, marketed in the US by Ortho Mcneil, a subsidiary of Johnson & Johnson.

Wockhardt plans to launch the product immediately upon expiration of the patent on June 20, 2011.

So, what do you think?  Will cheaper Lev be good for America?

Source: http://www.moneycontrol.com/news/business/wockhardt-gets-tentative-usfda-nod-for-levofloxacin_435543.html

Bookmark It

Hide Sites